For radioligands without a reference region, the Lassen plot can be used to estimate receptor occupancy by an exogenous drug (). However, the Lassen plot is not well-suited for spatial variation in . To overcome this limitation, we introduce a Lassen plot filter, i.e. a Lassen plot applied to local neighborhoods in PET images. Image data were simulated with regional variation in , , both, or neither and analyzed using the change in binding potential (), the conventional Lassen plot, and the Lassen plot filter at the region of interest (ROI) and voxel level. All methods were also applied to a human [C]flumazenil occupancy study using PF-06372865. This combination of a non-selective radioligand and selective drug should lead to varying provided the distribution of subtypes varies spatially. In contrast with and the conventional Lassen plot, ROI-level and voxel-level Lassen plot filter estimates remained unbiased in the presence of regional variation in or . In the [C]flumazenil data-set, was shown to vary regionally in accordance with the distribution of binding sites for [C]flumazenil and PF-06372865. We demonstrate that a local-neighborhood Lassen plot filter provides robust and unbiased estimates of and without the need for any user intervention.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142134 | PMC |
http://dx.doi.org/10.1177/0271678X20950486 | DOI Listing |
Anesth Analg
November 2024
Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California.
Niels Lassen's seminal 1959 cerebral autoregulation plot, a cornerstone in understanding the relationship between mean arterial pressure (MAP) and cerebral blood flow (CBF), was based on preexisting literature. However, this work has faced criticism for selective data presentation, leading to inaccurate interpretation. This review revisits and validates Lassen's original plot using contemporary data published since 2000.
View Article and Find Full Text PDFTher Adv Med Oncol
October 2024
Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Background: Dysregulated pathways in cancer may be hub addicted. Identifying these dysregulated networks for targeting might lead to novel therapeutic options.
Objective: Considering the hypothesis that central hubs are associated with increased lethality, identifying key hub targets within central networks could lead to the development of novel drugs with improved efficacy in advanced metastatic solid tumors.
EJNMMI Res
June 2024
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Background: In preclinical studies, the positron emission tomography (PET) imaging with [C]UCB-A provided promising results for imaging synaptic vesicle protein 2A (SV2A) as a proxy for synaptic density. This paper reports the first-in-human [C]UCB-A PET study to characterise its kinetics in healthy subjects and further evaluate SV2A-specific binding.
Results: Twelve healthy subjects underwent 90-min baseline [C]UCB-A scans with PET/MRI, with two subjects participating in an additional blocking scan with the same scanning procedure after a single dose of levetiracetam (1500 mg).
Eur J Nucl Med Mol Imaging
September 2024
Epilepsy Clinic, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen O, 2100, Denmark.
EJNMMI Phys
December 2023
Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Background: Drug occupancy studies with positron emission tomography imaging are used routinely in early phase drug development trials. Recently, our group introduced the Lassen Plot Filter, an extended version of the standard Lassen plot to estimate voxel-level occupancy images. Occupancy images can be used to create an EC image by applying an E model at each voxel.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!